GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » AI/ML Innovations Inc (FRA:42FB) » Definitions » Debt-to-EBITDA

AI/ML Innovations (FRA:42FB) Debt-to-EBITDA : -0.07 (As of Jan. 2024)


View and export this data going back to 2020. Start your Free Trial

What is AI/ML Innovations Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

AI/ML Innovations's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was €0.10 Mil. AI/ML Innovations's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was €0.00 Mil. AI/ML Innovations's annualized EBITDA for the quarter that ended in Jan. 2024 was €-1.35 Mil. AI/ML Innovations's annualized Debt-to-EBITDA for the quarter that ended in Jan. 2024 was -0.07.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for AI/ML Innovations's Debt-to-EBITDA or its related term are showing as below:

FRA:42FB' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -4.85   Med: -0.62   Max: 2.98
Current: -0.11

During the past 13 years, the highest Debt-to-EBITDA Ratio of AI/ML Innovations was 2.98. The lowest was -4.85. And the median was -0.62.

FRA:42FB's Debt-to-EBITDA is ranked worse than
100% of 419 companies
in the Healthcare Providers & Services industry
Industry Median: 2.57 vs FRA:42FB: -0.11

AI/ML Innovations Debt-to-EBITDA Historical Data

The historical data trend for AI/ML Innovations's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AI/ML Innovations Debt-to-EBITDA Chart

AI/ML Innovations Annual Data
Trend Apr13 Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.82 -3.27 -2.38 -0.12 -0.08

AI/ML Innovations Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Jul23 Oct23 Jan24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.18 -0.18 -0.18 -0.11 -0.07

Competitive Comparison of AI/ML Innovations's Debt-to-EBITDA

For the Health Information Services subindustry, AI/ML Innovations's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AI/ML Innovations's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, AI/ML Innovations's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where AI/ML Innovations's Debt-to-EBITDA falls into.



AI/ML Innovations Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

AI/ML Innovations's Debt-to-EBITDA for the fiscal year that ended in Apr. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.125 + 0.067) / -2.524
=-0.08

AI/ML Innovations's annualized Debt-to-EBITDA for the quarter that ended in Jan. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.098 + 0) / -1.352
=-0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jan. 2024) EBITDA data.


AI/ML Innovations  (FRA:42FB) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


AI/ML Innovations Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of AI/ML Innovations's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


AI/ML Innovations (FRA:42FB) Business Description

Traded in Other Exchanges
Address
645 Fort Street, Suite 203, Victoria, BC, CAN, V8W 1G2
AI/ML Innovations Inc has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence and machine learning, with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. The company has strategic partnerships with Health Gauge, Tech2Health and other planned accretive investments.

AI/ML Innovations (FRA:42FB) Headlines

No Headlines